characteristics.text: ERC000011
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: 2014-04-03T17:00:38Z
characteristics.characteristic: ENA-FIRST-PUBLIC
characteristics.text: 2014-01-23T21:30:19Z
characteristics.characteristic: ENA-LAST-UPDATE
characteristics.text: SAMEA2452561
characteristics.characteristic: External Id
characteristics.text: ERASMUSMC_HEMA
characteristics.characteristic: INSDC center name
characteristics.text: 2014-04-03T17:00:38Z
characteristics.characteristic: INSDC first public
characteristics.text: 2014-01-23T21:30:19Z
characteristics.characteristic: INSDC last update
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS395870
characteristics.characteristic: SRA accession
characteristics.text: 3q_seq_U937
characteristics.characteristic: Submitter Id
characteristics.text: human
characteristics.characteristic: common name
characteristics.text: This cell line has no apparent 3q-aberration. The cell line does not expresses the proto-oncogene EVI1. U937 cells were cultured in 90% RPMI and 10% FBS. The culture contained 50 U/ml penicillin and 50 μg/ml streptomycin (Sigma). Cell acquisition ATCC (CRL­1593.2)
characteristics.characteristic: description
characteristics.text: Homo sapiens
characteristics.characteristic: organism
characteristics.text: Homo sapiens
characteristics.characteristic: scientific_name
characteristics.text: 3q-Seq
characteristics.characteristic: title